ABG Innovation Capital Partners III’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-375,000
| Closed | -$4K | – | 5 |
|
|
2022
Q3 | $4K | Hold |
375,000
| – | – | 0.27% | 5 |
|
|
2022
Q2 | $6K | Hold |
375,000
| – | – | 0.45% | 6 |
|
|
2022
Q1 | $469K | Hold |
375,000
| – | – | 32.06% | 2 |
|
|
2021
Q4 | $435K | Hold |
375,000
| – | – | 25.16% | 3 |
|
|
2021
Q3 | $720K | Hold |
375,000
| – | – | 29.91% | 2 |
|
|
2021
Q2 | $878K | Hold |
375,000
| – | – | 2.94% | 2 |
|
|
2021
Q1 | $1.02M | Hold |
375,000
| – | – | 0.5% | 3 |
|
|
2020
Q4 | $908K | Buy |
+375,000
| New | +$908K | 0.53% | 3 |
|